© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
Biosimilars Fan Club Includes Free-Market Conservatives
July 06, 2020
Pacific Research Institute’s Winegarden Sees Dose of Competition as Way to Lower OOP Costs
Word From FDA, NIH on COVID-19 Vaccine: No Cutting Corners
July 05, 2020
FDA outlines what it will take to get a COVID-19 vaccine approved, while NIH offers its research strategy.
Could COVID-19 Winnow Out Low-Value Cancer Care?
July 02, 2020
Authors of JAMA Oncology opinion piece see priorities set in response to the pandemic as a chance to discourage low-value cancer care.
Survey: Rheumatologists Still Reluctant to Switch Patients to Biosimilars
July 02, 2020
Cardinal Health recently conducted a survey of more than 100 rheumatologists asking their feelings about biosimilars, and the findings revealed that the majority of them were familiar with and comfortable prescribing biosimilars.
Convergence of Dental, Health Insurance Increases
July 02, 2020
Of the 87% of executives who see convergence already happening, 89% say it is accelerating—up from 21% who said the same in 2018.
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
July 01, 2020
In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.
Q&A With Don McDaniel
July 01, 2020
The veteran healthcare executive says this may be a Netflix vs. Blockbuster moment for hospitals. And health plans may be under pressure to meet the statutory levels for medical spending and recontract with their networks to offer enhanced payments in return for clinical improvement activities.
How Proactive Patient Engagement Can Influence Patient Health During COVID-19
July 01, 2020
More than half of approximately 600 consumers (52%) surveyed in mid-March—the time when major metropolitan areas began issuing “shelter-in-place” orders and encouraging “social distancing”—said they had not been given direct guidance from either their payers or providers regarding the novel coronavirus.